Clearmind Medicine

CMND · NASDAQ

$5.87−$0.13 (−2.17%)TodayMarket closed ·
Prev close $6.00

About CMND

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.

Employees
0
Headquarters
Vancouver, Ontario
Listed
Aug 10, 2021
Sector
Health Care
Industry
Pharmaceuticals

CMND key statistics

Market cap
2.98M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
22.69K
Volume
8.56K
Open price
$6.10
High today
$6.26
Low today
$5.87
52 Week high
$3,840.00
52 Week low
$5.25

Clearmind Medicine (CMND) at a glance

As of Oct 23, 2026, Clearmind Medicine (CMND) shares are priced at $5.87, giving the company a market cap of 2.98M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $5.87 and $6.26. The current price is 0.0% above the day's low and 6.2% below its high.

Volume so far is 8.56K shares, below the average of 22.69K shares a day.

Over the past year Clearmind Medicine has ranged from $5.25 to $3,840.00, and now sits 0% of the way up that range.

CMND news

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Henry Khederian

    Clearmind Medicine Stock Slides Friday: What's Happening?

  • Vandana Singh

    Clearmind Medicine Makes Clinical Progress in Alcohol Addiction Treatment Trial

  • Avi Kapoor

    Gold Falls 1%; Amer Sports Earnings Top Views

  • Avi Kapoor

    Dow Falls Over 100 Points; Home Depot Posts Upbeat Earnings

  • Avi Kapoor

    Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

  • Avi Kapoor

    Dow Gains Over 200 Points; US Retail Sales Top Estimates

  • Avi Kapoor

    Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.